Publikationen

Publikationen 2019

Bertero E, Ameri P, Maack C. (2019) Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology. Card Fail Rev. 5:106-111.

Bertero E, Maack C. (2019) The Partial AdeNosine A1 receptor agonist in patients with Chronic Heart failure and preserved Ejection fraction (PANACHE) trial. Cardiovasc Res. 115:e71-e73.

Bertero E, Sequeira V, Heymans S, Maack C. (2019) Response to 'The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes'. Eur Heart J.

de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschope C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C, Heymans S. (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European journal of heart failure.

Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Stork S, consortium S, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R. (2019) Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study. Int J Cardiol. 286:186-189.

Nickel AG, Kohlhaas M, Bertero E, Wilhelm D, Wagner M, Sequeira V, Kreusser MM, Dewenter M, Kappl R, Hoth M, Dudek J, Backs J, Maack C. (2019) CaMKII Does not Control Mitochondrial Ca(2+) Uptake in Cardiac Myocytes. The Journal of physiology.

Seidlmayer LK, Mages C, Berbner A, Eder-Negrin P, Arias-Loza PA, Kaspar M, Song M, Dorn GW, II, Kohlhaas M, Frantz S, Maack C, Gerull B, Dedkova EN. (2019) Mitofusin 2 Is Essential for IP3-Mediated SR/Mitochondria Metabolic Feedback in Ventricular Myocytes. Front Physiol. 10:733.

Sequeira V, Bertero E, Maack C. (2019) Energetic drain driving hypertrophic cardiomyopathy. FEBS Lett.

Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW. (2019) The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J. 40:2155-2163.

Publikationen 2018

Angermann CE, Frantz S, Maack C. (2018) The Comprehensive Heart Failure Centre in Wurzburg, Germany. Eur Heart J. 39:1757-1760.

Bertero E, Canepa M, Maack C, Ameri P. (2018) Linking Heart Failure to Cancer. Circulation. 138:735-742.

Bertero E, Maack C. (2018) Reply to 'Metabolic remodelling in heart failure revisited'. Nat Rev Cardiol. 15:780-781.

Bertero E, Maack C. (2018) Metabolic remodelling in heart failure. Nat Rev Cardiol. 15:457-470.

Bertero E, Maack C. (2018) Calcium Signaling and Reactive Oxygen Species in Mitochondria. Circ Res. 122:1460-1478.

Bertero E, Maack C, O'Rourke B. (2018) Mitochondrial transplantation in humans: "magical" cure or cause for concern? J Clin Invest. 128:5191-5194.

Bertero E, Prates Roma L, Ameri P, Maack C. (2018) Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc Res. 114:12-18.

Bertero E, Sequeira V, Maack C. (2018) Let's face the fats: Palmitate restores cellular redox state in the diabetic heart. The Journal of physiology.

Bertero E, Sequeira V, Maack C. (2018) Hungry Hearts. Circ Heart Fail. 11:e005642.

Bohm M, Komajda M, Borer JS, Ford I, Maack C, Tavazzi L, Moyne A, Swedberg K, Investigators S. (2018) Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT. European journal of heart failure. 20:373-381.

Chowdhury A, Aich A, Jain G, Wozny K, Luchtenborg C, Hartmann M, Bernhard O, Balleiniger M, Alfar EA, Zieseniss A, Toischer K, Guan K, Rizzoli SO, Brugger B, Fischer A, Katschinski DM, Rehling P, Dudek J. (2018) Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1alpha Expression in Hypoxia. Cell Rep. 2018;25:561-570 e6.

Diebold S, Moellmann J, Kahles F, Haj-Yehia E, Liehn EA, Nickel A, Lebherz C, Maack C, Marx N, Lehrke M. (2018) Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity. Diabetes Obes Metab. 20:2911-2918.

Kazakov A, Hall RA, Werner C, Meier T, Trouvain A, Rodionycheva S, Nickel A, Lammert F, Maack C, Bohm M, Laufs U. (2018) Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress. Basic Res Cardiol. 113:42.

Lehmann LH, Jebessa ZH, Kreusser MM, Horsch A, He T, Kronlage M, Dewenter M, Sramek V, Oehl U, Krebs-Haupenthal J, von der Lieth AH, Schmidt A, Sun Q, Ritterhoff J, Finke D, Volkers M, Jungmann A, Sauer SW, Thiel C, Nickel A, Kohlhaas M, Schafer M, Sticht C, Maack C, Gretz N, Wagner M, El-Armouche A, Maier LS, Londono JEC, Meder B, Freichel M, Grone HJ, Most P, Muller OJ, Herzig S, Furlong EEM, Katus HA, Backs J. (2018) A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. Nature medicine. 24:62-72.

Lourenco AP, Leite-Moreira AF, Balligand JL, Bauersachs J, Dawson D, de Boer RA, de Windt LJ, Falcao-Pires I, Fontes-Carvalho R, Franz S, Giacca M, Hilfiker-Kleiner D, Hirsch E, Maack C, Mayr M, Pieske B, Thum T, Tocchetti CG, Brutsaert DL, Heymans S. (2018) An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. European journal of heart failure. 20:216-227.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A. (2018) Treatments targeting inotropy. Eur Heart J.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, Gonzalez A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S. (2018) Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology. Eur Heart J. 39:4243-4254.

Meli AC, Maack C. (2018) Scientists on the Spot: Christoph Maack on how to measure mitochondrial parameters in cardiomyocytes. Cardiovasc Res. 114:e84-e86.

Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Stork S, consortium S, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R. (2018) Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study. Int J Cardiol.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Bohm M, Marx N, Floege J, Fliser D, Jankowski J. (2018) The new SFB/TRR219 Research Centre. Eur Heart J. 39:975-977.

Sequeira V, Maack C. (2018) Rebalancing protein phosphorylation in heart failure to prevent arrhythmias. European journal of heart failure. 20:1686-1689.

Publikationen 2017

Bertero E, Prates Roma L, Ameri P, Maack C. (2017) Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc Res.

Böhm M, Komajda M, Borer JS, Ford I, Maack C, Tavazzi L, Moyne A, Swedberg K, Investigators S. (2017) Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT. European journal of heart failure.

Cabezas-Wallscheid N, Buettner F, Sommerkamp P, Klimmeck D, Ladel L, Thalheimer FB, Pastor-Flores D, Roma LP, Renders S, Zeisberger P, Przybylla A, Schönberger K, Scognamiglio R, Altamura S, Florian CM, Fawaz M, Vonficht D, Tesio M, Collier P, Pavlinic D, Geiger H, Schroeder T, Benes V, Dick TP, Rieger MA, Stegle O, Trumpp A. (2017) Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy. Cell. 169:807-823.e19.

Dietl A, Maack C. (2017) Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure. Curr Heart Fail Rep. 14:338-349.

Dudek J, Maack C. (2017) Barth syndrome cardiomyopathy. Cardiovascular Research. 113:399-410.

Heggermont WA, Papageorgiou AP, Quaegebeur A, Deckx S, Carai P, Verhesen W, Eelen G, Schoors S, van Leeuwen R, Alekseev S, Elzenaar I, Vinckier S, Pokreisz P, Walravens AS, Gijsbers R, Van Den Haute C, Nickel A, Schroen B, van Bilsen M, Janssens S, Maack C, Pinto Y, Carmeliet P, Heymans S. (2017) Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. Circulation. 136:747-761.

Kohlhaas M, Nickel AG, Bergem S, Casadei B, Laufs U, Maack C. (2017) Endogenous nitric oxide formation in cardiac myocytes does not control respiration during β-adrenergic stimulation. The Journal of physiology. 595:3781-3798.

Kohlhaas M, Nickel AG, Maack C. (2017) Mitochondrial energetics and calcium coupling in the heart. The Journal of physiology. 595:3753-3763.

Maack C, Murphy E. (2017) Metabolic cardiomyopathies: fighting the next epidemic. Cardiovascular Research. 113:367-369.

Münzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. (2017) Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series. J Am Coll Cardiol. 70:212-229.

Siede D, Rapti K, Gorska AA, Katus HA, Altmuller J, Boeckel JN, Meder B, Maack C, Volkers M, Muller OJ, Backs J, Dieterich C. (2017) Identification of circular RNAs with host gene-independent expression in human model systems for cardiac differentiation and disease. J Mol Cell Cardiol. 109:48-56.

Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J, Silvola JM, Roivainen A, Saraste A, Nickel AG, Saar JA, Sieve I, Pietzsch S, Muller M, Bogeski I, Kappl R, Jauhiainen M, Thackeray JT, Scherr M, Bengel FM, Hagl C, Tudorache I, Bauersachs J, Maack C, Hilfiker-Kleiner D. (2017) Low STAT3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 38:349-361.

van Bilsen M, Patel HC, Bauersachs J, Bohm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, Floras J, Grassi G, Jankowska EA, Kornet L, Lunde IG, Maack C, Mahfoud F, Pollesello P, Ponikowski P, Ruschitzka F, Sabbah HN, Schultz HD, Seferovic P, Slart R, Taggart P, Tocchetti CG, Van Laake LW, Zannad F, Heymans S, Lyon AR. (2017) The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure. 19:1361-1378.

von Hardenberg A, Maack C. (2017) Mitochondrial Therapies in Heart Failure. Handb Exp Pharmacol. 243:491-514.

Publikationen 2016

Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, De Boer RA, van der Meer P, Maack C, Mouquet F, Petrie MC, Piepoli MF, Regitz-Zagrosek V, Schaufelberger M, Seferovic P, Tavazzi L, Ruschitzka F, Mebazaa A, Sliwa K. (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European journal of heart failure. 18:1096-105.

Fujikawa Y, Roma LP, Sobotta MC, Rose AJ, Diaz MB, Locatelli G, Breckwoldt MO, Misgeld T, Kerschensteiner M, Herzig S, Müller-Decker K, Dick TP. (2016) Mouse redox histology using genetically encoded probes. Science Signaling. 9:rs1-rs1.

Linicus Y, Kindermann I, Cremers B, Maack C, Schirmer S, Bohm M. (2016) Vena cava compression syndrome in patients with obesity presenting with edema and thrombosis. Obesity. 24:1648-52.

Maack C. (2016) The cardiac re-AKT-ion to chronic volume overload. European journal of heart failure. 18:372-4.

Maack C. (2016) Orphaned mitochondria in heart failure. Cardiovasc Res. 109:6-8.

Maack C. (2016) Der Einfluss von Ivabradin auf die kardiale Funktion. WMW Skriptum. 13:27-29.

Puhl SL, Kazakov A, Müller A, Fries P, Wagner DR, Böhm M, Maack C, Devaux Y. (2016) Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1-adrenoceptor stimulation in vivo. British Journal of Pharmacology. 173:88-102.

Seiler F, von Hardenberg A, Bohm M, Bals R, Maack C. (2016) Cardiopulmonary Comorbidities. Dtsch Med Wochenschr. 141:275-82; quiz 283-4.

Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J, Silvola JM, Roivainen A, Saraste A, Nickel AG, Saar JA, Sieve I, Pietzsch S, Muller M, Bogeski I, Kappl R, Jauhiainen M, Thackeray JT, Scherr M, Bengel FM, Hagl C, Tudorache I, Bauersachs J, Maack C, Hilfiker-Kleiner D. (2016) Low STAT3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J.

Wolf S, Hainz N, Beckmann A, Maack C, Menger MD, Tschernig T, Meier C. (2016) Brain damage resulting from postnatal hypoxic-ischemic brain injury is reduced in C57BL/6J mice as compared to C57BL/6N mice. Brain research. 1650:224-231.

Publikationen 2015

Böhm M, Robertson M, Ford I, Borer JS, Komajda M, Kindermann I, Maack C, Lainscak M, Swedberg K, Tavazzi L. (2015) Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial). The American journal of cardiology.

Clancy CE, Chen-Izu Y, Bers DM, Belardinelli L, Boyden PA, Csernoch L, Despa S, Fermini B, Hool LC, Izu L, Kass RS, Lederer WJ, Louch WE, Maack C, Matiazzi A, Qu Z, Rajamani S, Rippinger CM, Sejersted OM, O'Rourke B, Weiss JN, Varro A, Zaza A. (2015) Deranged sodium to sudden death. The Journal of physiology. 593:1331-45.

Kazakov A, Meier T, Werner C, Hall R, Klemmer B, Körbel C, Lammert F, Maack C, Böhm M, Laufs U. (2015) C-kit resident cardiac stem cells improve left ventricular fibrosis in pressure overload. Stem cell research. 15:700-711.

Lenski M, Schleider G, Kohlhaas M, Adrian L, Adam O, Tian Q, Kaestner L, Lipp P, Lehrke M, Maack C, Böhm M, Laufs U. (2015) Arrhythmia causes lipid accumulation and reduced glucose uptake. Basic Res Cardiol. 110:40.

Münzel T, Gori T, Keaney JF, Jr., Maack C, Daiber A. (2015) Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J. 36:2555-64.

Murphy Michael P. (2015) Redox Modulation by Reversal of the Mitochondrial Nicotinamide Nucleotide Transhydrogenase. Cell Metabolism. 22:363-365.

Nickel AG, von Hardenberg A, Hohl M, Löffler JR, Kohlhaas M, Becker J, Reil JC, Kazakov A, Bonnekoh J, Stadelmaier M, Puhl SL, Wagner M, Bogeski I, Cortassa S, Kappl R, Pasieka B, Lafontaine M, Lancaster CR, Blacker TS, Hall AR, Duchen MR, Kaestner L, Lipp P, Zeller T, Müller C, Knopp A, Laufs U, Böhm M, Hoth M, Maack C. (2015) Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure. Cell Metab. 22:472-84.

Perttunen H, Maack C. (2015) Pericardial effusion associated with hypothyroidism in an adult female with Down syndrome. American journal of medical genetics Part A.

Puhl SL, Kazakov A, Müller A, Fries P, Wagner DR, Böhm M, Maack C, Devaux Y. (2015) A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to alpha1-adrenergic stimulation in vivo. Br J Pharmacol.

Puhl SL, Müller A, Wagner M, Devaux Y, Böhm M, Wagner DR, Maack C. (2015) Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice. American journal of physiology Heart and circulatory physiology. 2015;309:H345-59.

Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schafer F, Wagner N, Ergun S, Schmitt JP, Katus HA, Weidemann F, Ravens U, Maack C, Hein L, Ertl G, Müller OJ, Maier LS, Lohse MJ, Lorenz K. (2015) Cardiac RKIP induces a beneficial beta-adrenoceptor-dependent positive inotropy. Nature medicine. 21:1298-306.

Publikationen 2014

Hohl M, Ardehali H, Azuaje FJ, Breckenridge RA, Doehner W, Eaton P, Ehret GB, Fujita T, Gaetani R, Giacca M, Hasenfuss G, Heymans S, Leite-Moreira AF, Linke WA, Linz D, Lyon A, Mamas MA, Oresic M, Papp Z, Pedrazzini T, Piepoli M, Prosser B, Rizzuto R, Tarone G, Tian R, van Craenenbroeck E, van Rooij E, Wai T, Weiss G, Maack C. (2014) Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research. European journal of heart failure. 16:6-14.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M. (2014) Task Force for the D and Management of Acute Pulmonary Embolism of the European Society of C. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 35:3033-69, 3069a-3069k.

Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman M, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M. (2014) ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego do spraw rozpoznawania i postepowania w ostrej zatorowosci p. Kardiol Pol. 72:997-1053.

Kreusser MM, Lehmann LH, Keranov S, Hoting MO, Oehl U, Kohlhaas M, Reil JC, Neumann K, Schneider MD, Hill JA, Dobrev D, Maack C, Maier LS, Grone HJ, Katus HA, Olson EN, Backs J. (2014) Cardiac CaM Kinase II genes delta and gamma contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy. Circulation. 130:1262-73.

Nickel A, Kohlhaas M, Maack C. (2014) Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 73C:26-33.

Nickel A, Kohlhaas M, Maack C. (2014) Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 73:26-33.

Task Force M, Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M and Authors/Task Force M. (2014) ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J. 35:3033-73.

Weinreuter M, Kreusser MM, Beckendorf J, Schreiter FC, Leuschner F, Lehmann LH, Hofmann KP, Rostosky JS, Diemert N, Xu C, Volz HC, Jungmann A, Nickel A, Sticht C, Gretz N, Maack C, Schneider MD, Grone HJ, Muller OJ, Katus HA, Backs J. (2014) CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury. EMBO molecular medicine. 6:1231-45.

Kontakt, Öffnungszeiten, Sprechzeiten

Öffnungszeiten der Herzinsuffizienz-Ambulanz

Montag bis Donnerstag
08:00 bis 16:30 Uhr

Freitag
08:00 bis 15:00 Uhr

Telefon

Herzinsuffizienz-Ambulanz
+49 931 201-46301

Geschäftsstelle
+49 931 201-46333


Anschrift

Deutsches Zentrum für Herzinsuffizienz Würzburg | Universitätsklinikum Würzburg | Am Schwarzenberg 15 | Haus A15 | 97078 Würzburg | Deutschland

schließen